[1]
Sanmati K. Jain et al. 2022. QSAR Investigation on 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carbothioamides as EGFR Kinase Inhibitors. Challenges and Advances in Pharmaceutical Research Vol. 2. (Apr. 2022), 58–70. DOI:https://doi.org/10.9734/bpi/capr/v2/15743D.